In recognition of Clinical Trials Day, The Trial for #ClinicalEquality –a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company – continues the fight to increase equity in clinical trials with the next phase of its campaign entitled, “Worth Less.”
Earlier this month, Neuralink said tiny wires implanted in the brain of its first patient had pulled out of position. Reuters reported last week, citing sources, the company knew from animal testing that the wires might retract.
H4B Chelsea President Violet Aldaia was recently elected the new board chair of the Coalition for Healthcare Communication (CHC). Med Ad News spoke with Aldaia to get a quick take on the issues she feels are most important for CHC to address this year.
Pfizer’s Wyeth unit notched a legal victory over AstraZeneca on Friday as a federal jury found the British-Swedish company violated two key patents in developing and marketing its lung cancer drug Tagrisso.
In an oral decision, the European patent authority maintained the validity of Moderna’s patent ‘949 which describes and protects specific alterations to mRNA molecules designed to lower its immunogenicity, bypass the immune system and boost its translation in the body—as well as the potential uses of the modified mRNA.
According to key opinion leaders (KOLs) interviewed by GlobalData, the prevalence of HIV will reduce in the future, partly due to better treatment options, the availability of PrEP, and the development of prophylactic vaccines.